Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NIH, BRAIN Research Gets Boost In 2014 Senate Labor/HHS Bill

This article was originally published in The Gray Sheet

Executive Summary

An appropriations bill passed by a Senate committee would increase the National Institutes of Health’s funding by $307 million to $31 billion in fiscal year 2014, including $40 million for President Obama’s BRAIN neurotechnology research initiative. Senate Appropriations Committee Chair Barbara Mikulski says she is determined to bring the Labor/HHS funding bill to the floor for debate.

You may also be interested in...



Long-Time HELP Democrat Sen. Barbara Mikulski Plans To Retire By 2017

Maryland Sen. Barbara Mikulski (D), the body’s longest-serving female Senator, former Appropriations Committee Chair and advocate of quality and comparative effectiveness provisions in the Affordable Care Act, recently announced her plans not to seek re-election in 2016 and retire.

Director Collins Implores Congress To Set Predictable NIH Funding Growth

The best way to accelerate medical cures, National Institutes of Health Director Francis Collins tells a congressional 21st Century Cures coalition, is to make sure that NIH researchers are supplied with a steady, predictable source of grant funding.

Friendly Fire? Tavenner Nomination Held Up By Sen. Harkin

While the Senate Finance Committee April 23 agreed to endorse Marilyn Tavenner to head CMS, Sen. Tom Harkin, D-Iowa, Chairman of the Senate HELP Committee, put a block on her full Senate approval the next day.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032228

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel